StonvexLoading…
StonvexStonvexStonvexCore line items from ROIV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-03-31 | Annual 2024 2024-03-31 | Annual 2023 2023-03-31 | Annual 2022 2022-03-31 |
|---|---|---|---|---|
Revenue | $29.05M | $32.71M | $31.53M | $55.29M |
Operating Income | $-1.00B | $4.50B | $-906.76M | $-1.35B |
Net Income | $-171.98M | $4.35B | $-1.01B | $-845.26M |
EPS (Diluted) | $-0.24 | $5.23 | $-1.42 | $-1.26 |
Total Assets | $5.44B | $7.22B | $2.39B | $2.59B |
Total Liabilities | $249.74M | $773.95M | $782.02M | $523.70M |
Cash & Equivalents | $2.72B | $6.49B | $1.68B | $2.06B |
Free Cash Flow OCF − CapEx | $-844.05M | $-766.65M | $-856.08M | $-695.16M |
Shares Outstanding | 695.94M | 806.68M | 760.14M | 694.98M |